Experiments were conducted with fetal lambs of 113–120 days gestation (0.8 term) to assess the integrity of adrenergic neurotransmission at the level of the blood vessels. Regional blood flow and the distribution of blood from the inferior vena cava were compared when the arterial pressure was increased either by an infusion of exogenous noradrenaline or when tyramine was used to evoke a local release of the neurotransmitter. Most vascular beds perfused via the descending aorta were constricted to a similar extent by both drugs although the renal circulation did not respond to tyramine. Noradrenaline increased the distribution of blood from the inferior vena cava to the fetal lungs and both drugs increased placental blood flow. These data indicate that mechanisms for effective adrenergic control of vascular resistance are developed in many organs of the premature lamb fetus by 0.8 of term.

Keywords:
Fetus, Sheep, Development, Adrenergic transmission, Radioactive microspheres, Regional blood flow
This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.